✦ LIBER ✦

Cost-effectiveness of using recombinant factor VIIa (rFVIIa) in a massive transfusion protocol for severe blunt trauma

✍ Scribed by Mayur B. Patel; Judson B. Williams; Syamal D. Bhattacharya; Richard S. Miller; John A. Morris; Oscar D. Guillamondegui

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The evidence for the use of recombinant

✍ C. J. Moltzan; D. A. Anderson; J. Callum; S. Fremes; H. Hume; C. D. Mazer; M. C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Cost effectiveness of recombinant activa

✍ S. Morris; S. Ridley; V. Munro; M. C. Christensen; the NovoSeven® Trauma Study G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB